FT : Arm takes action to regain control at its renegade China unit

Arm takes action to regain control at its renegade China unit
UK chip designer will this week submit paperwork in Shenzhen in effort to replace chief executive Allen Wu

Arm has moved to regain control of its renegade China unit and replace its chief executive Allen Wu, as the UK chip designer seeks to clear its path to a successful public listing.

The UK chip designer will put forward two individuals to act as co-chief executives of its China joint venture and has received official sign-off to submit the paperwork, according to two people with direct knowledge of the matter.

The proposed candidates to take over as co-CEOs are Dr Liu Renchen, a government adviser and vice-dean of the Research Institute of Tsinghua University in Shenzhen and Vision Fund managing partner Eric Chen, who has been leading SoftBank’s negotiations with Chinese officials.

Arm has been trying to oust Wu for almost two years, after he disregarded a 7 to 1 board vote for his removal and unilaterally took control of the company.

“Discussions have been going on for a while and this is the proposed solution,” said one person close to Arm China’s board. “But submission is not the problem, getting authorities to sign off on it is,” the person said.

The person noted that prior deals to resolve the stand-off had fallen through at the last minute and cautioned: “We still have to see if Allen will be able to derail it.”

People close to the matter say Arm’s move to transfer shares of the joint venture to SoftBank had spurred Chinese officials to action in an effort to maintain the UK chip designer’s stake in the unit.

Last week’s appointment of a new Communist party secretary, Meng Fanli, in Shenzhen has also helped speed up difficult negotiations over removing Arm China chief Wu, the people said.

The talks between Arm, its owner SoftBank and representatives of the Shenzhen government have been going on for months, with Chinese officials determined to use the impasse with Wu to ensure the country’s continued access to the UK company’s semiconductor blueprints. Arm’s chip designs power almost every smartphone.

Wu’s possession of Arm China’s “chop” — through which official documents are authorised — and position as the company’s legal representative has made it difficult to remove him under Chinese law, making government intervention necessary.

The paperwork to be submitted in Shenzhen proposes to replace Wu as the company’s legal representative with Liu and enables the company to make a new chop, the two people said.

Arm’s proposed share transfer, which spurred the government action, would leave the UK chip designer owning less than 10 per cent of the China venture, down from 47.3 per cent today. This would remove the need to audit Arm China’s financials for an IPO.

The prospect of Arm withdrawing from the venture, or retaining only a very small stake, has made stakeholders in China uneasy.

“Can you even call it ‘Arm China’ without Arm,” said one person close to the company.

It has also become clear in recent weeks that leaving Wu in place threatened to undermine Arm’s business and could be an obstacle to gaining strong investor interest in the listing.

Arm China has a perpetual and exclusive licence to market and sell Arm’s chip blueprints in the country and receives a cut of the sales. But for its internally developed intellectual property (IP), it receives 100 per cent of the income.

The structure’s inherent incentives mean that in practice Wu works to sell as much of Arm China’s internally developed IP as possible, often by bundling it with deals for Arm’s IP, three people close to the company said. They added that demand for Arm China’s IP was probably not high.

“It’s hard to say if Arm China’s [proprietary] IP is actually worth anything. All customers are forced to buy it to get Arm’s IP and they also have to say good things about it,” said one person close to Arm China.

Arm declined to comment. A spokesperson for Wu and Arm China did not immediately respond to questions on his removal, but said Arm China relied on Arm’s “comprehensive global pricing system” to price deals and that its self-developed IP had had “strong market success”.

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • NCR -18.3%, FFIV -8.7%, CHKP -7%, JNPR -6.4%, DB -6.3%, COF -5.5%, ETR -5%, GOOG -4.4%, GRMN -4.3%, EW -3.7%, PRG -3.7%, TXN -3.4%, HIW -3.4%, TPB -3.2%, BA -3.1%, DAN -2.4%, ACMR -2.1%, APAM -1.5%, BHE -1.4%, HOG -1.4%, MKSI -1.2%, TENB -0.9%, ROL -0.9%, OSK -0.7%

Other news:

  • MOLN -36.8% (MOLN to regain global rights for MP0310 from AMGN)
  • SEV -10.3% (launches proposed follow-on offering of 10 mln shares)
  • GMDA -5.9% (updated one-year post-transplant data presented on omidubicel at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings)
  • MNKD -4.8% (presented a poster at the 15th International Conference on Advanced Technologies & Treatments for Diabetes)
  • DCPH -4.1% (prices offering of common stock and pre-funded warrants)
  • HOOD -3.7% (eliminates 9% of its full-time employees)
  • ETD -1.4% (increases dividend)
  • TWTR -1% (discloses $1 bln parent termination fee in merger agreement with Elon Musk)

Analyst comments:

  • COF -5.5% (downgraded to Neutral from Overweight at Piper Sandler)
  • JBLU -2.2% (downgraded to Underweight from Overweight at JP Morgan)
  • SKYW -1.6% (downgraded to Mkt Perform from Outperform at Raymond James)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • ASH +9.6%, ENPH +8.2%, TX +6.1%, SKX +5.6%, V +5.5%, CSGP +5.4%, WNC +4.8%, ARLP +4.7%, CHEF +4.7%, BYD +4.3%, CTOS +4.2% (also CFO to step down), CVE +4.1%, MSFT +3.9%, FCPT +3.4%, TECK +3.4%, EXAS +3.3%, ACCO +3.3%, BSX +3.3%, TMUS +3.2%, TER +3.1%, OC +3.1%, RHI +3%, BG +2.7%, TDY +2.7%, CMG +2.6%, GM +2.3%, GSK +2.1%, UMC +2.1%, MTDR +1.9%, EEFT +1.9%, SPOT +1.9%, RRC +1.7%, IQV +1.6%, NEO +1.6%, ODFL +1.5%, SF +1.4%, STM +1.3%, LYG +1.3%, GD +1.1%, MAS +1.1%, MDLZ +1%, HES +1%

Other news:

  • ZNTL +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
  • PCT +5% (SEC concludes investigation without further action)
  • ARLP +4.7% (increases dividend; provides prelim qtrly results)
  • DWAC +4.5% (currently #1 on Apple's App Store)
  • LCID +3.8% (announces large EV purchase deal with Saudi Arabia)
  • BG +2.6% (announces commercial partnership with CoverCress)
  • AZN +1.9% (reports ENHERTU granted Breakthrough Therapy Designation in U.S. for patients with HER2 low metastatic breast cancer)
  • GLPG +1.4% (names new chairman)
  • HAS +1.1% (activist Alta Fox wants to replace HAS's Chairman according to Bloomberg)

Analyst comments:

  • RSI +4.3% (upgraded to Overweight from Equal Weight at Wells Fargo)
  • HAL +1.4% (upgraded to Buy from Hold at HSBC Securities)
  • SLB +1.4% (upgraded to Buy from Hold at HSBC Securities)

>>> US Research Calls

Research Calls

  • Upgrades:
    • Avery Dennison (AVY) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $195
    • Ares Capital (ARCC) upgraded to Overweight from Neutral at JP Morgan; tgt $22
    • Brookfield Asset Mgmt (BAM) upgraded to Outperform from Neutral at Credit Suisse; tgt raised to $71.50
    • Ecolab (ECL) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $190
    • Estee Lauder (EL) upgraded to Buy from Hold at Edward Jones
    • Franklin Electric (FELE) upgraded to Buy from Neutral at Seaport Research Partners
    • Halliburton (HAL) upgraded to Buy from Hold at HSBC Securities; tgt raised to $41.60
    • Robert Half (RHI) upgraded to Buy from Neutral at BofA Securities; tgt raised to $133
    • Rush Street Interactive (RSI) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $10
    • Schlumberger (SLB) upgraded to Buy from Hold at HSBC Securities; tgt raised to $44.20
  • Downgrades:
    • BNY Mellon (BK) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $51.50
    • Capital One (COF) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $143
    • Robert Half (RHI) upgraded to Buy from Neutral at BofA Securities; tgt raised to $133
    • Euronav (EURN) downgraded to Hold from Buy at Jefferies; tgt lowered to $12
    • JetBlue Airways (JBLU) downgraded to Underweight from Overweight at JP Morgan; tgt lowered to $12
    • Molecular Partners AG (MOLN) downgraded to Neutral from Buy at Kempen; tgt $10
    • Molecular Partners AG (MOLN) downgraded to Underperform from Neutral at Credit Suisse
    • PotlatchDeltic (PCH) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $60
    • SkyWest (SKYW) downgraded to Mkt Perform from Outperform at Raymond James
  • Others:
    • Appian (APPN) initiated with a Buy at Goldman; tgt $70
    • Aecom Tech (ACM) initiated with an Outperform at RBC Capital Mkts; tgt $91
    • Aldeyra Therapeutics (ALDX) assumed with a Buy at H.C. Wainwright; tgt $15
    • Cazoo (CZOO) initiated with a Neutral at UBS; tgt $2.60
    • Insmed (INSM) initiated with a Buy at Goldman; tgt $56
    • Jacobs Engineering (J) initiated with an Outperform at RBC Capital Mkts; tgt $173
    • Organon (OGN) initiated with a Buy at Goldman; tgt $40
    • Royalty Pharma (RPRX) initiated with a Buy at Goldman; tgt $56
    • UroGen Pharma (URGN) initiated with a Buy at Berenberg; tgt $20
    • Vor Biopharma (VOR) initiated with a Neutral at Goldman; tgt $6
    • WalkMe Ltd. (WKME) initiated with a Buy at Goldman; tgt $23
    • Warner Bros. Discovery (WBD) initiated with an Equal Weight at Barclays; tgt $24

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • ASH +9.6%, ENPH +8.6%, ARLP +7.6%, LCID +7%, TX +6.1%, DWAC +5.8%, V +5.5%, CSGP +5.4%, MSFT +5.4%, MNKD +4.8%, BYD +4.3%, SKX +4.3%, GM +3.8%, CNI +3.6%, CMG +3.6%, FCPT +3.4%, TER +3.4%, ACCO +3.3%, TENB +3.3%, EXAS +3.2%, CVE +3.2%, CTOS +3.1%, LYG +2.6%, DMTK +2.5%, CSTM +2.3%, AZN +2.2%, OC +2.1%, RHI +2%, GSK +2%, MTDR +1.9%, EEFT +1.9%, QS +1.5%, STM +1.5%, TECK +1.4%, XOM +1.3%, MDLZ +1.3%, CGC +1.1%, CS +1%, BG +1%, IPAR +0.9%, MET +0.8%, AIR +0.8%, HAS +0.8%
  • Gapping down:
    • MOLN -37.6%, NCR -19.8%, SEV -10%, FFIV -8.7%, DB -5.9%, JNPR -5.2%, EW -5.1%, MKSI -5%, COF -4.7%, CHKP -4.3%, HA -3.8%, DCPH -3.5%, HIW -3.4%, GOOG -3.2%, TXN -2.4%, TWTR -1.8%, APAM -1.5%, ETD -1.4%, BHE -1.4%, WH -1.4%, HOOD -0.8%, PLYM -0.8%, SPOT -0.6%, NAVI -0.5%

>>> Europe : Brokers Upgrades & Downgrades - 26th of April 2022 V2(+)

>>> Up
* Carlsberg Raised to Buy at Deutsche Bank; PT 1,000 kroner
* Halliburton Raised to Buy at HSBC; PT $41.60
* eQ Raised to Accumulate at Inderes; PT 26 euros
* Estee Lauder Raised to Buy at Edward Jones
* Evotec SE Raised to Buy at FMR Frankfurt Main; PT 39 euros
* Novozymes Raised to Hold at Nordea
* Plus500 Raised to Buy at Peel Hunt; PT 1,860 pence
* Saab PT Raised to 458 kronor from 300 kronor at Citi
* Schlumberger NV Raised to Buy at HSBC; PT $44.20
* SSAB Raised to Add at AlphaValue/Baader
* System1 Raised to Buy at Canaccord; PT 385 pence (+)

>>> Down
* AB Foods Cut to Neutral at Grupo Santander; PT 2,150 pence
* Allegro Cut to Neutral at JPMorgan; PT 33.70 zloty
* Campari Cut to Hold at Deutsche Bank; PT 10.70 euros
* Collector Cut to Hold at SEB Equities; PT 45 kronor
* Diageo Cut to Hold at Deutsche Bank; PT 3,900 pence
* Hugo Boss Cut to Add at Baader Helvea; PT 56 euros
* Kering Cut to Hold at HSBC; PT 600 euros
* Molecular Partners Cut to Neutral at Kempen & Co (+)

>>> Initiation
* Euronav Reinstated Hold at Jefferies; PT 11.26 euros
* Flyr Rated New Buy at SpareBank; PT 3 kroner
* S4 Capital Rated New Buy at Citi

>>> Call
* Air Liquide 1Q Sales Beat; Jefferies Notes Gas Unit Rise (+)
* Boohoo’s FY23 Outlook in Focus at Next Week’s Results: Jefferies (+)
* Deutsche Bank Raises Carlsberg While Cutting Diageo, Campari (+)
* Drax Update Strong and Points to Upside Beyond 2022, RBC Says (+)
* DSV 1Q Strong, Guidance Upped; Citi Sees Higher FY Consensus (+)
* Handelsbanken 1Q Margins Should be Well Received, Citi Says (+)
* Melexis Guidance ‘Well Ahead’ of Expectations, Jefferies Says (+)
* Mercedes 1Q Results ‘Very Strong,’ Outlook Confirmed: Jefferies (+)
* Orsted Downgraded to Sell at Citi on ‘Valuation Mismatch’
* S4 Capital Gets Another Buy as Citi Cites Growth, De-Rating
* STMicro 1Q Sales Top Estimate, 2H Now More Conservative: Citi (+)
* Symrise Posts 1Q Sales Beat, Jefferies Sees Shares Supported (+)

>>> Stoxx 600 Pre-Market Indications

  • Equinor (DNQ TH) +5.6%
    • Equinor Plans New Gas Pipeline From Castberg, Wisting: DN
  • Commerzbank (CBK TH) +5.2%
  • Michelin (MCH TH) +4.6%
    • Michelin’s Maintained Guidance Should Be a Positive: Street Wrap
  • Atos (AXI TH) +2.5%
    • Atos 1Q Revenue Beats Estimates
  • Qiagen (QIA TH) +2.4%
  • Mercedes (MBG TH) +2.1%
    • Mercedes 1Q Sales Beats Estimates
  • Rio Tinto (RIO1 TH) +2%
  • Puma (PUM TH) +1.9%
  • Santander (BSD2 TH) +1.9%
  • Coloplast (CBHD TH) +1.7%
  • K+S (SDF TH) -0.9%
  • HeidelbergCement (HEI TH) -0.9%
  • Delivery Hero (DHER TH) -1%
  • LVMH (MOH TH) -1.2%
  • Mowi (PND TH) -1.3%
  • Nokia (NOA3 TH) -1.3%
  • Lanxess (LXS TH) -1.3%
  • Glencore (8GC TH) -1.3%
  • Solvay (SOL TH) -1.4%
  • CD Projekt (7CD TH) -2.4%

>>> TradeGate Pre-Market Indications

DAX:
  • Puma (PUM TH) +2.6%
  • Deutsche Bank (DBK TH) +2.1%
    • Deutsche Bank’s Traders Take Sewing Closer to Profit Goal (1)
  • Mercedes (MBG TH) +2.1%
    • Mercedes 1Q Sales Beats Estimates
  • Adidas (ADS TH) +1.3%
    • Florida SBA Backs Adidas on 8 of 8 Proposals at May 12 AGM
  • Continental (CON TH) +1.1%
  • RWE (RWE TH) -0.7%
MDAX:
  • Software AG (SOW TH) +6.9%
    • Software AG 1Q Adjusted Ebita Beats Estimates
  • Commerzbank (CBK TH) +6.2%
    • GERMANY DAYBOOK: Weapons Shift, Deutsche Bank, Commerzbank
  • Thyssenkrupp (TKA TH) +1.6%
  • Evotec SE (EVT TH) +1.3%
    • Evotec SE Raised to Buy at FMR Frankfurt Main; PT 39 euros
  • Lanxess (LXS TH) -1%
  • Aixtron (AIXA TH) -1%
    • Asian Chip Stocks Drop After Texas Instruments, Hynix Misses
SDAX:
  • flatexDEGIRO (FTK TH) +4.1%
    • flatexDEGIRO 1Q Adjusted Ebitda EU54.5M
  • Deutsche Euroshop (DEQ TH) +3.4%
  • MorphoSys (MOR TH) +1.5%
  • LPKF (LPK TH) +1.2%
  • PVA TePla (TPE TH) +1.2%
  • Jenoptik (JEN TH) -1.4%
  • Shop Apotheke (SAE TH) -1.4%
    • Online Pharmacies Surge After German Health Minister Comment
  • VERBIO (VBK TH) -1.5%

>>> Europe : Brokers Upgrades & Downgrades - 26th of April 2022

>>> Up
* Carlsberg Raised to Buy at Deutsche Bank; PT 1,000 kroner
* Halliburton Raised to Buy at HSBC; PT $41.60
* eQ Raised to Accumulate at Inderes; PT 26 euros
* Estee Lauder Raised to Buy at Edward Jones
* Evotec SE Raised to Buy at FMR Frankfurt Main; PT 39 euros
* Novozymes Raised to Hold at Nordea
* Plus500 Raised to Buy at Peel Hunt; PT 1,860 pence
* Saab PT Raised to 458 kronor from 300 kronor at Citi
* Schlumberger NV Raised to Buy at HSBC; PT $44.20
* SSAB Raised to Add at AlphaValue/Baader

>>> Down
* AB Foods Cut to Neutral at Grupo Santander; PT 2,150 pence
* Allegro Cut to Neutral at JPMorgan; PT 33.70 zloty
* Campari Cut to Hold at Deutsche Bank; PT 10.70 euros
* Collector Cut to Hold at SEB Equities; PT 45 kronor
* Diageo Cut to Hold at Deutsche Bank; PT 3,900 pence
* Hugo Boss Cut to Add at Baader Helvea; PT 56 euros
* Kering Cut to Hold at HSBC; PT 600 euros

>>> Initiation
* Euronav Reinstated Hold at Jefferies; PT 11.26 euros
* Flyr Rated New Buy at SpareBank; PT 3 kroner
* S4 Capital Rated New Buy at Citi

>>> CallOrsted Downgraded to Sell at Citi on ‘Valuation Mismatch’
*
* S4 Capital Gets Another Buy as Citi Cites Growth, De-Rating

>>> What to look et today - 26th of April 2022

Most Asian stocks fell Wednesday as mixed corporate earnings, China’s Covid challenges and the prospect of aggressive Federal Reserve monetary tightening pointed to a deteriorating economic outlook. Japan dragged an Asia-Pacific share gauge to the lowest since 2020 after U.S. shares slid Tuesday, hurt by a technology-sector selloff. S&P 500 and Nasdaq 100 futures stabilized, while European contracts dipped.  China’s bourses bucked the downbeat Asian trend, carving out a gain after President Xi Jinping vowed more infrastructure projects -- the latest step to support a lockdown-hit economy. The Covid outbreaks in Shanghai and Beijing also showed tentative signs of steadying. Prevailing risk aversion supported the dollar, which was around the highest level in nearly two years.  Treasuries retreated but the benchmark 10-year yield, at 2.76%, remains lower for the week.
The euro touched the weakest level versus the greenback since 2017 amid worries that Moscow may choke gas flows to Europe, hurting the region’s growth in the ongoing fallout from Russia’s invasion of Ukraine. Russia will cut off supplies to Poland and Bulgaria Wednesday, making good on a threat to halt flows to nations that refuse to pay for the fuel in rubles. Oilheld at $101 a barrel, with Europe mulling curbs on Russian crude. The energy brinkmanship and disappointment over earnings from the likes of Alphabet Inc. and Texas Instruments Inc. sowed further doubts about the outlook for markets. The mood was already fragile due to Fed tightening to quell runaway inflation and slowing activity in China as Covid lockdowns bite. Australia’s dollar rallied after core inflation breached the top of the central bank’s 2%-3% target for the first time since 2010. Swaps traders fully priced in a 15-basis-point hike for next month’s policy meeting. US After Hours After Hours Summary: MSFT +6%, ENPH +5.5%, CMG +5.1%, V +4.2% higher on earnings; NCR -17.4%, FFIV -8.7%, JNPR -6.9%, EW -5.2%, TXN -4.2%, GOOG -2.9% lower on earnings

Nikkei -1.15% Hang Seng +0.46% CSI +2.33% Shanghai +1.82% Shenzen +3.11%

Eur$ 1.0653 CNH 6.5813 CNY 6.5499 JPY 127.57 GBP 1.2592 CHF 0.9626 RUB 75.4255 TRY 14.8053 WTI$ 101.87 +0.17% Gold 1,99.25 -0.33% BTC 38,425 +0.80% ETH 2,845 +0.55%

S&P +0.47% Nasdaq +0.35% EuroStoxx -0.08% FTSE +0.04% Dax -0.18% SMI -0.26%

Macro :
- Russia to Cut Gas to Poland and Bulgaria, Making Energy a Weapon
- Euro Falls to Five-Year-Low Against Dollar as Growth Risks Eyed
- Chinese Drone Maker DJI to Suspend Businesses in Russia, Ukraine
- Austria Not Seeing Reduction in Russian Gas Deliveries: Minister

Keep an eye on :
- ADEN SW : Robert Half 1Q EPS Beats Estimates
- ADP FP : ADP 1Q Revenue Misses Estimates
- AENA SM : Aena 1Q Net Loss EU96.4M, Est. Loss EU21.7M
- AIR FP : Boeing’s Cash Burn a Concern With 787 Delivery Halt: Preview
- ALV GY : Allianz, Axa and Zurich Face Scrutiny on Response to Inflation
- ALO FP : Bombardier Bonds Sink After Alstom Requests Arbitration
- GOOGL US : Alphabet Slides After Revenue Misses Expectations: Street Wrap
- ATO FP : Atos 1Q Revenue Beats Estimates
- CS FP : Allianz, Axa and Zurich Face Scrutiny on Response to Inflation
- BB FP : BIC Sees FY Net Sales Ex-FX High End of +7% to +9%
- BT/A LN : BT Eyes Big Quantum Sales After EY Joins Trial With Toshiba
- CLN SW : *CLARIANT TO REPLACE CFO AS PROBE ENDS WITH RESTATEMENTS
- CBK GY : Commerzbank 12% Revenue Surge, 1Q Beat Defy Share Plunge: React
- CSGN SW : Credit Suisse 1Q Net Loss CHF273M, Est. Loss CHF114.9M
- DSY FP : Dassault Systemes Sees FY Non-Ifrs EPS +9% to +11%
- DBK GY : Deutsche Bank Raises 2022 Investment Bank Revenue Forecast
- DNB NO : DNB Sues Norway State Over Interest Deduction for U.S. Unit: FA
- DSM NA : Elanco Secures U.S. Rights to DSM’s Methane-Reducing Additive
- DSV DC : DSV Boosts FY Ebit Pre-Items Forecast, Beats Estimates
- DWS GY : DWS 1Q Net Outflows Misses Estimates
- FGR FP : Eiffage, Termotecnica Sign EU345M Port Deal in Colombia
- ELK NO : Elkem 1Q Ebitda Beats Estimates
- EMSN SW : EMS-Chemie 1Q Net Sales CHF638M Vs. CHF566M Y/y
- EQNR NO : Equinor Plans New Gas Pipeline From Castberg, Wisting: DN
- FTK GY : flatexDEGIRO 1Q Adjusted Ebitda EU54.5M
- GJF NO : Gjensidige 1Q Pretax Profit Misses Estimates
- SHBA SS : Handelsbanken First-Quarter Earnings Beat Amid Lending Growth
- HUH1V FH : Huhtamaki 1Q Adjusted Ebit Beats Estimates
- ITP FP : Interparfums 1Q Sales at Constant Exchange Rates +18.1%
- IPN FP : Ipsen 1Q Sales Beats Estimates
- KAMBI SS : Kambi 1Q Revenue Misses Estimates
- KEMIRA FH : Kemira 1Q Oper Ebitda Beats Estimates
- KCR FH : Konecranes 1Q Net Sales Misses Estimates
- LUNE SS : Lundin Energy 1Q Ebitda Beats Estimates
- MAT US : Mattel Said to Hold Talks on Buyout With Private Equity Firms
- MELE BB : Melexis Boosts FY Operating Margin Forecast
- MBG GY : Mercedes 1Q Adjusted Ebit Beats Estimates
- ML FP : Michelin CFO Says Ukraine War Adds About EU1B in Costs This Year
- MSFT US : *MICROSOFT EXTENDS POSTMARKET GAINS TO 6% AFTER FORECASTS
- NEX FP : Nexans 1Q Revenue EU1.62B Vs. EU1.50B Y/y
- ORSTED DC : Orsted Says Gazprom Hasn’t Reached Out Regarding Danish Supply
- PNDXB SS : Pandox 1Q Ebitda Misses Estimates
- POM FP : Plastic Omnium Maintains FY Operating Margin Forecast
- PLUS LN : Plus500 Rating, Estimates Raised at Peel Hunt After Strong 1Q
- QIA GY : Qiagen Boosts FY Adjusted EPS Forecast
- RKT LN : Reckitt Benckiser seeks up to $10bn for remainder of infant milk business
- REE SM : Red Electrica 1Q Net Income EU182.1M
- RHM GY : Slovenia to Buy 45 Boxer Armored Vehicles for EU343m: STA
- RNO FP : Renault May Give AvtoVAZ Stake to Russia’s NAMI Institute: IFX
- RESURS SS : Resurs Holding 1Q Operating Income Beats Estimates
- RILBA DC : Rilba 1Q Pretax Profit Beats Estimates
- SU FP : Schneider Electric 1Q Revenue Beats Estimates
- SEBA SS : SEB 1Q Net Interest Income Beats Estimates
- STM FP : STMicroelectronics 2Q Net Revenue Forecast Beats Estimates
- STM FP : China Lockdowns Weigh on Chip Makers
- SUSE GY : EQT Said to Have Explored Sale of SUSE After Interest
- SY1 GY : Symrise 1Q Sales Beats Estimates
- TKA AV : Telekom Austria 1Q Net Income Beats Estimates
- TELIA SS : Telia CEO Says Share Buyback Program to Begin End of 2Q
- TEMN SW : Temenos 1Q Non-Ifrs Revenue Meets Estimates
- TWTR US : Twitter/Musk Deal Terms Include $1b Termination Fee
- UNI SM : Unicaja 1Q Net Income Misses Estimates
- UN01 GY : Uniper Warns of 2 Billion-Euro Loss from Nord Stream-2 Pipeline
- FR FP : Valeo’s Outlook Confirmation Based on Lower Siemens JV Losses
- VAR NO : Var Energi 1Q Net Income Meets Estimates
- XXL NO : XXL 1Q Ebitda Misses Estimates
- WLN FP : Worldline 1Q Revenue Beats Estimates